SFWJ / Medcana Announces Strategic Expansion Into Australia With Acquisition of Cannabis Import and Distribution Licenses

Rhea-AI Summary

Software Effective Solutions Corp. (OTC:SFWJ), operating as Medcana, has announced its strategic expansion into the Australian market through the acquisition of pharmaceutical cannabis import and distribution licenses. The move represents a significant milestone in the company's global growth strategy.

The newly acquired licenses will enable Medcana to import and distribute pharmaceutical-grade cannabis products in Australia, allowing the company to establish distribution partnerships and meet the growing regional demand for medical cannabis. This expansion strengthens Medcana's international presence, particularly in Latin America and the Asia-Pacific region.

Positive

• Expansion into new geographic market (Australia)
• Acquisition of strategic pharmaceutical cannabis licenses
• Enhanced global supply chain capabilities
• Access to growing Australian medical cannabis market

Negative

• None.

AUSTIN, TX / ACCESS Newswire / April 19, 2025 / Software Effective Solutions Corp. (OTC:SFWJ), doing business as Medcana, today announced it is proceeding with the acquisition of pharmaceutical cannabis licenses to import and distribute cannabis in Australia.

This move marks a significant milestone in Medcana's global growth strategy. By entering the Australian market, Medcana further strengthens its international footprint in the medical cannabis industry and enhances its global capabilities in both production and distribution of pharmaceutical-grade cannabis products.

The acquired licenses will allow Medcana to import high-quality, research-driven cannabis products into Australia and establish distribution partnerships to meet the growing demand for medical cannabis in the region.

José Gabriel Díaz, CEO of Medcana, commented:
"This is a pivotal step forward for Medcana. Expanding into Australia is not only a strategic decision-it solidifies our position as a global player in the medical cannabis sector. With operations now reaching into Latin America and the Asia-Pacific region, we're uniquely positioned to lead the international supply chain for pharmaceutical cannabis."

About Medcana

Medcana is a U.S.-based public company operating in the international medical cannabis sector. Through its Colombian operations and strategic partnerships, Medcana is focused on the production, research, and global distribution of high-quality pharmaceutical-grade cannabis products.

For investor relations or media inquiries, please contact:

investors@medcana.co
http://www.medcana.co/
Twitter: @MedcanaCo

SOURCE: Software Effective Solutions

View the original press release on ACCESS Newswire

FAQ

What licenses did SFWJ acquire in Australia in April 2025?

SFWJ acquired pharmaceutical cannabis import and distribution licenses in Australia, enabling the company to import and distribute medical cannabis products in the country.

How will the Australian license acquisition impact SFWJ's global presence?

The acquisition expands SFWJ's international footprint by establishing operations in the Asia-Pacific region, complementing its existing presence in Latin America.

What is the strategic significance of SFWJ's Australian market entry?

The expansion strengthens SFWJ's position in the global medical cannabis sector and enhances its international supply chain capabilities for pharmaceutical cannabis.

What activities will SFWJ's new Australian licenses permit?

The licenses will allow SFWJ to import high-quality, research-driven cannabis products and establish distribution partnerships in Australia.